See what SCRIMED can sell, prove, and pilot for your organization.

Bind every synthetic agent run to context, policy, and proof

• Status: ready-for-synthetic-execution
• Mode: synthetic_recommendation_only
• Human review required: yes
• Proof routes: /scrimed-intelligence-platform, /scrimed-trustops, /workflows/execution-attempts
• Blocked: live PHI, autonomous clinical decision, EHR writeback, patient outreach

Create a governed release train for workflows and services

• Status: ready-for-synthetic-execution
• Mode: human_review_queue_only
• Human review required: yes
• Proof routes: /service-delivery, /release-continuity, /boundary-release-approvals, /qa-evidence
• Blocked: payer submission, billing submission, EHR writeback, customer go-live approval

Harden infrastructure readiness with cleanup, integrity, and smoke gates

• Status: in-progress
• Mode: read_only_metadata
• Human review required: no
• Proof routes: /production-architecture, /release-candidate-readiness, /navigation
• Blocked: deploy without gates, secret-dependent CI path, unreviewed generated artifacts

Make product and UI readiness navigable from one command surface

• Status: ready-for-synthetic-execution
• Mode: read_only_metadata
• Human review required: no
• Proof routes: /product, /hub, /navigation, /scrimed-operating-command
• Blocked: hidden authority expansion, claims without evidence, route sprawl without navigation

Tie products, services, demos, pilots, and pricing to delivery proof

• Status: ready-for-synthetic-execution
• Mode: synthetic_recommendation_only
• Human review required: yes
• Proof routes: /offerings, /pricing, /demos, /pilots, /service-delivery
• Blocked: signed contract creation, calendar invite automation, autonomous email send, revenue guarantee

Advance interoperability through validation adapters, not raw connector access

• Status: blocked-by-approval
• Mode: protected_operator_run_required
• Human review required: yes
• Proof routes: /clinical-data-fabric, /health-records, /interoperability, /clinical-data-governance
• Blocked: raw connector payload logging, live PHI ingestion, production connector activation, EHR writeback

scrimed-operating-evidence-agent-runtime-context-binding

• Lane: agent-runtime-context-binding
• Missing evidence: human-review-disposition
• AAL2 required: no
• Boundary release required: no
• Hash: d003294d1d7ad939

scrimed-operating-evidence-workflow-orchestration-release-train

• Lane: workflow-orchestration-release-train
• Missing evidence: human-review-disposition, fresh-aal2-operator-run
• AAL2 required: yes
• Boundary release required: yes
• Hash: f675ed503078ce95

scrimed-operating-evidence-infrastructure-reliability-control-loop

• Lane: infrastructure-reliability-control-loop
• Missing evidence: current-gate-pass-evidence
• AAL2 required: no
• Boundary release required: no
• Hash: 2d8cfb02e0f4350f

scrimed-operating-evidence-product-interface-command-surface

• Lane: product-interface-command-surface
• Missing evidence: none
• AAL2 required: no
• Boundary release required: yes
• Hash: f8badb99afb745ec

scrimed-operating-evidence-service-product-packaging-loop

• Lane: service-product-packaging-loop
• Missing evidence: human-review-disposition
• AAL2 required: no
• Boundary release required: yes
• Hash: 078a99e31513d1c4

scrimed-operating-evidence-interoperability-safety-adapter-lane

• Lane: interoperability-safety-adapter-lane
• Missing evidence: human-review-disposition, fresh-aal2-operator-run, external-approval-artifact
• AAL2 required: no
• Boundary release required: yes
• Hash: ca04b9a4fb7aa947

Release Smoke Autopilot

• Domain: release-readiness
• Readiness: 92
• Human review required: yes
• Production authority: blocked
• Next: Generate a no-secret release checklist from the latest local validation run.

Service Delivery Autopilot

• Domain: service-delivery
• Readiness: 89
• Human review required: yes
• Production authority: blocked
• Next: Attach every sellable package to a repeatable no-PHI work-order starter.

Buyer Follow-Up Autopilot

• Domain: sales-revenue
• Readiness: 84
• Human review required: yes
• Production authority: blocked
• Next: Create one human-reviewed follow-up packet per buyer audience.

Agent Approval Autopilot

• Domain: agent-operations
• Readiness: 88
• Human review required: yes
• Production authority: blocked
• Next: Precompute allow/deny/review decisions from session state before tool execution.

Security Evidence Autopilot

• Domain: security-governance
• Readiness: 86
• Human review required: yes
• Production authority: blocked
• Next: Bind security evidence to buyer-safe questionnaire answer starters.

Integration Readiness Autopilot

• Domain: interoperability
• Readiness: 81
• Human review required: yes
• Production authority: blocked
• Next: Generate a no-PHI connector discovery packet with retained production-approval blockers.

Customer go-live readiness can be confused with demo readiness.

• Current limit: No customer go-live authority exists until customer-specific controls, contracts, security review, and support model are approved.
• Escalation: Any buyer asks to connect live systems, process PHI, or rely on SCRIMED for care delivery.
• Proof route: /service-delivery

Operator time is lost assembling the same proof routes for buyers, investors, and reviewers.

• Current limit: Proof packets remain human-reviewed and cannot be externally distributed automatically.
• Escalation: External distribution, buyer-specific diligence, or claims language expansion is requested.
• Proof route: /scrimed-proof-packet-studio

Pressure to automate can blur safe internal automation and prohibited healthcare actions.

• Current limit: High-risk clinical, payer, outreach, connector, credential, and production actions remain blocked.
• Escalation: Action touches patient safety, legal, billing, external communication, infrastructure mutation, or production systems.
• Proof route: /scrimed-agent-governance

Custom work, provider spend, and model route expansion can erode pilot margins.

• Current limit: Pricing exceptions and external provider spend require human finance review.
• Escalation: Projected spend, custom scope, or model route exceeds the package guardrail.
• Proof route: /enterprise-business-ops

Clinical production pressure before approvals are complete

• Status: human-review-required
• Priority: 94
• Human review: required
• Next: Add every live-care, PHI, diagnosis, treatment, prescribing, payer, or EHR request to the approval path before any sales or delivery promise expands.
• Proof routes: /clinical-production-readiness, /clinical-authority-readiness, /global-certification-readiness, /scrimed-automation-autopilot

Automation must accelerate work without gaining unsafe authority

• Status: human-review-required
• Priority: 91
• Human review: required
• Next: Route new automation requests through the Autopilot decision evaluator before implementation.
• Proof routes: /scrimed-automation-autopilot, /scrimed-agent-governance, /scrimed-trustops, /workflows/runtime-safety

Health-system interoperability expectations must stay synthetic until approved

• Status: external-approval-required
• Priority: 89
• Human review: tracked
• Next: Attach connector questions to a no-PHI technical diligence packet with explicit profile, license, security, and customer-approval gates.
• Proof routes: /enterprise-healthcare-infrastructure, /interoperability, /health-records, /limitations-workarounds

Investor proof must show operating depth without overclaiming

• Status: human-review-required
• Priority: 87
• Human review: required
• Next: Create a one-page investor proof ladder from Product Console, Public Market Readiness, and Proof Packet Studio.
• Proof routes: /investor-audience-readiness, /product, /scrimed-proof-packet-studio, /company-assessment

International expansion requires claims-safe localization

• Status: human-review-required
• Priority: 86
• Human review: required
• Next: Package the top launch and strategic regions into localized, no-PHI, human-reviewed proof packets.
• Proof routes: /global-enterprise-command, /global-reach, /global-certification-readiness, /client-onboarding

Interoperable solution accelerator

• Mode: recommendation-only
• Commercial motion: Package as interoperability readiness and hospital IT discovery before protected pilot scope.
• Next: Create a buyer-specific integration discovery packet that maps standards, systems, VPN/VM/firewall needs, and owner approvals.
• Proof routes: /enterprise-healthcare-infrastructure, /health-records, /healthcare-intelligence-os#clinical-context-gateway

Clinical workflow burden reduction

• Mode: human-reviewed-draft
• Commercial motion: Sell as a no-PHI clinical workflow assessment and documentation optimization pilot.
• Next: Bind each burden-reduction workflow to a structured review packet, evidence card, and clinician signoff state.
• Proof routes: /healthcare-intelligence-os, /healthcare-intelligence-os#clinical-context-gateway, /scrimed-agent-governance

Agent capability expansion with approval gates

• Mode: synthetic-orchestration
• Commercial motion: Demonstrate governed agents as enterprise workflow infrastructure rather than simple chat automation.
• Next: Register each healthcare optimization agent with owner, scope, allowed data class, blocked tools, and audit hash.
• Proof routes: /scrimed-automation-autopilot, /scrimed-agent-governance, /scrimed-trustops

Hospital operations throughput intelligence

• Mode: synthetic-orchestration
• Commercial motion: Sell as hospital operations optimization and service-line intelligence readiness.
• Next: Add an operations signal catalog that converts synthetic events into owner, severity, fallback, and evidence requirements.
• Proof routes: /operational-efficiency, /service-reliability, /scrimed-trustops

Innovation-to-pilot pipeline

• Mode: recommendation-only
• Commercial motion: Use as a founder and enterprise innovation command lane for buyer-specific pilot design.
• Next: Add innovation intake scoring that ranks ideas by buyer value, safety, feasibility, proof routes, and margin potential.
• Proof routes: /strategic-problem-resolution, /scrimed-proof-packet-studio, /pilot-demo-commercial-readiness

30-day workflow value discovery

• Artifact: No-PHI workflow value map with owner-bound next actions and retained hard stops.
• Boundary: Measurement framework only; not an ROI guarantee or clinical outcome claim.
• Metrics: documentation-time-saved-proxy, missing-documentation-risk-reduction, problem-resolution-value-closure
• Proof routes: /healthcare-optimization-command, /strategic-problem-resolution, /service-delivery

60-day no-PHI operations optimization pilot

• Artifact: Synthetic dashboard packet with signal review, owner routing, and human escalation records.
• Boundary: No patient outreach, scheduling, operational command, or live-care authority.
• Metrics: referral-cycle-time-readiness, follow-up-completion-readiness, hospital-capacity-signal-review
• Proof routes: /health-records, /scrimed-patient-context-gateway, /enterprise-healthcare-infrastructure

90-day enterprise value evidence packet

• Artifact: Diligence-ready evidence ledger with audit hashes, no-go boundaries, and release prerequisites.
• Boundary: Not certification, valuation assurance, securities material, or customer go-live approval.
• Metrics: agent-trace-completeness, source-contract-completeness, investor-proof-completeness
• Proof routes: /investor-readiness, /investor-audience-readiness, /scrimed-llmops-observability

Interoperability readiness value packet

• Artifact: Connector discovery matrix with standards map, proof routes, and approval blockers.
• Boundary: Not production connector approval, raw schema exposure, or EHR writeback.
• Metrics: interoperability-discovery-completeness, source-contract-completeness, agent-trace-completeness
• Proof routes: /enterprise-healthcare-infrastructure, /clinical-data-fabric, /scrimed-hybrid-retrieval

Workflow discovery evidence packet

• Review gate: Clinical operations reviewer approval before buyer distribution.
• Commercial next step: Convert to paid workflow discovery assessment with retained no-live-care boundary.
• Boundary: Not an ROI guarantee, audited labor-savings report, or clinical outcome claim.
• Acceptance: Synthetic baseline and target packet are both audit-hashed. Every clinical-facing output is reviewer-gated. Blocked claims include ROI, staffing reduction, and clinical outcome guarantees.

RCM documentation evidence packet

• Review gate: RCM compliance reviewer approval.
• Commercial next step: Offer a review-gated RCM documentation readiness pilot.
• Boundary: No payer submission, billing submission, coverage determination, or reimbursement guarantee.
• Acceptance: Payer submission remains blocked. Each missing documentation signal has source provenance. Reviewer signoff is required before external packet use.

Patient access evidence packet

• Review gate: Patient access lead and patient education reviewer approval.
• Commercial next step: Scope a patient engagement readiness pilot with no live outreach.
• Boundary: No live patient outreach, scheduling command, care-plan modification, or patient-specific medical advice.
• Acceptance: Synthetic-only patient journey scenarios are used. Human review and consent path are required for any live outreach. Education drafts preserve uncertainty and source attribution.

Interoperability diligence packet

• Review gate: Integration security reviewer and data governance owner approval.
• Commercial next step: Sell technical discovery before any connector implementation.
• Boundary: Not production connector approval, EHR writeback, raw schema review, or live PHI authorization.
• Acceptance: No raw schemas or connector payloads are exposed. Production connector approval remains external-review-required. EHR writeback and payer actions stay blocked.

Workflow discovery activation plan

• Source: Workflow discovery evidence packet
• Next: Create buyer-specific workflow discovery packet and schedule human-reviewed scope call.
• Boundary: Not live clinical care, audited savings, staffing reduction guarantee, or customer activation.
• Success: Buyer agrees to synthetic-only scope. Clinical reviewer gate is documented. Pilot outputs remain decision-support and measurement framework evidence.

RCM documentation activation plan

• Source: RCM documentation evidence packet
• Next: Attach buyer policy examples as synthetic metadata requirements, not live payer submission instructions.
• Boundary: No payer submission, claim submission, coverage determination, reimbursement guarantee, or payment assurance.
• Success: No payer submission or claim submission occurs. Documentation completeness is scored against synthetic requirements only. RCM compliance reviewer approves external summaries.

Patient access activation plan

• Source: Patient access evidence packet
• Next: Prepare accessibility-aware synthetic journey demos for the buyer's care coordination lane.
• Boundary: No patient outreach, appointment scheduling command, care-plan modification, or patient-specific medical advice.
• Success: No live patient outreach occurs. All patient-facing education remains draft and review-gated. Follow-up and referral signals remain synthetic or metadata-only.

Interoperability discovery activation plan

• Source: Interoperability diligence packet
• Next: Create a buyer-specific interoperability discovery worksheet.
• Boundary: Not production connector approval, EHR writeback, raw schema review, or live PHI authorization.
• Success: Only metadata-level interface information is used. No raw schemas or connector payloads are exposed. External technical approval remains required before implementation.

Buyer sponsor scope handoff

• Review gate: Founder or delivery lead approval required before any external send.
• Delivery: Human-reviewed email, meeting agenda, or buyer room note only.
• Blocked: No contract approval, pricing commitment, customer activation, live PHI request, or external send without review.
• Proof routes: /pilot-activation-planner, /api/pilot-activation-planner/brief, /pilot-value-evidence, /client-onboarding

Security and privacy review handoff

• Review gate: Security owner approval required before buyer security distribution.
• Delivery: Protected buyer room or human-reviewed email draft only.
• Blocked: No raw schemas, credentials, connector payloads, live PHI, or production integration approval.
• Proof routes: /pilot-activation-planner, /scrimed-cyber-defense, /enterprise-healthcare-infrastructure, /clinical-data-governance

Clinical governance handoff

• Review gate: Clinical governance owner approval required before clinical-facing language is shared.
• Delivery: Human-reviewed clinical governance packet only.
• Blocked: No diagnosis, treatment, prescribing, triage, final imaging interpretation, or live clinical action.
• Proof routes: /pilot-activation-planner, /clinical-production-readiness, /clinical-authority-readiness, /clinical-robustness-lab

Implementation kickoff handoff

• Review gate: Implementation lead approval required before scheduling or messaging.
• Delivery: Human-reviewed agenda or internal workspace packet.
• Blocked: No automated calendar invite, patient outreach, production access, or live system activation.
• Proof routes: /pilot-activation-planner, /service-delivery, /client-onboarding, /launch-readiness

30-day workflow-fit review

• Reviewer: Delivery Lead + Buyer Sponsor
• Safe output: Workflow-fit readiness summary with evidence gaps and retained no-go boundaries.
• Blocked: No productivity, ROI, savings, or staffing reduction guarantee.
• Proof routes: /pilot-value-evidence, /pilot-activation-planner, /pilot-handoff-command

30-day security and governance review

• Reviewer: Security + Data Governance
• Safe output: Security readiness note with unresolved approval blockers.
• Blocked: No certification, live PHI authorization, production connector approval, or security guarantee.
• Proof routes: /pilot-handoff-command, /scrimed-cyber-defense, /clinical-data-governance

60-day buyer adoption friction review

• Reviewer: Implementation Lead + Customer Success
• Safe output: Adoption friction map and owner-bound action register.
• Blocked: No customer activation approval, patient outreach approval, or operational outcome guarantee.
• Proof routes: /pilot-handoff-command, /service-delivery, /client-onboarding

60-day clinical governance review

• Reviewer: Clinical Governance
• Safe output: Clinical governance posture note with blocked authority claims.
• Blocked: No diagnosis, treatment, prescribing, triage, final imaging interpretation, or live-care claim.
• Proof routes: /pilot-handoff-command, /clinical-authority-readiness, /clinical-production-readiness

CarePath Access Operations Demo

• Pilot: 60-Day Governed Automation Pilot
• No autonomous outreach, diagnosis, treatment, emergency routing, PHI, or live workflow execution.

DocuTwin Documentation Review Demo

• Pilot: 60-Day Governed Automation Pilot
• No final note, EHR filing, diagnosis insertion, autonomous documentation, PHI, or clinical validation claim.

PayerIQ Documentation Readiness Demo

• Pilot: 60-Day Governed Automation Pilot
• No live PHI, medical-necessity determination, payer submission, appeal filing, EHR writeback, or reimbursement guarantee.

TrialCore Research Operations Demo

• Pilot: 60-Day Governed Automation Pilot
• No patient outreach, enrollment decision, treatment recommendation, PHI, or production research-record mutation.

Atlas Interoperability Readiness Demo

• Pilot: AI Governance + Interoperability Readiness Pilot
• No live healthcare data exchange, connector certification, trading-partner acceptance, or production mutation.

Sandbox DNS classifier

• Command: SCRIMED_PRIMARY_BASE_URL=https://app.scrimedsolutions.com SCRIMED_FALLBACK_BASE_URL=https://scrimed-site.vercel.app npm run smoke:launch-domain-preflight
• Pass: Primary domain resolves and returns SCRIMED health/readiness, or sandbox DNS failure is explicitly classified while fallback health/readiness passes for internal continuity.
• This does not bypass DNS, alter external records, or convert fallback-only evidence into launch approval.

Strict production smoke

• Command: SCRIMED_BASE_URL=https://app.scrimedsolutions.com SCRIMED_WORKSPACE_SLUG=atlas-synthetic-evaluation npm run smoke:public
• Pass: All public HTML routes, JSON APIs, Markdown briefs, headers, and protected fail-closed checks pass.
• The smoke suite does not approve protected AAL2 happy-path mutations or production clinical authority.

Domain ownership and route fallback

• Command: curl -L --max-time 20 -s -I https://app.scrimedsolutions.com/api/launch-readiness
• Pass: The branded domain returns launch-readiness headers and buyer routes load without Vercel-auth friction.
• Fallback routes are continuity aids, not a replacement for branded-domain launch readiness.

Custom domain and DNS preflight

• Gate: Primary branded domain must resolve and pass smoke from an unrestricted network before public launch approval.
• Workaround: When the managed sandbox returns ENOTFOUND, rerun production smoke with approved network access and use the fallback Vercel alias only as supporting evidence, not as launch approval.
• Hard stop: Do not mark launch green from fallback-only proof when the branded domain cannot be verified.

Source, build, and route inventory

• Gate: Typecheck, lint, build, navigation inventory, public smoke, and route counts must agree before external promotion.
• Workaround: If one dynamic detail route cannot be smoked, keep the canonical route smoke-covered and rely on build/typecheck for the dynamic segment until it becomes buyer-critical.
• Hard stop: Do not launch with missing primary navigation, stale route counts, or broken canonical buyer paths.

Product and offer packaging

• Gate: Every launch conversation has a sellable package, scope boundary, proof route, and next buyer action.
• Workaround: Use assessment or synthetic pilot packages when production connectors, PHI, customer proof, or live-care authority are not approved.
• Hard stop: Do not sell live clinical execution, EHR writeback, payer submission, or autonomous patient outreach.

Service delivery and onboarding

• Gate: Each opportunity has owner, stage, communication packet, proof routes, scope, retained boundary, and next meeting artifact.
• Workaround: Use manual human-send communications and no-PHI meeting packets until email/calendar automation and CRM sync are approved.
• Hard stop: Do not auto-send emails, create calendar invites, bind contracts, store PHI, or promise procurement approval.

Enterprise operations and margin control

• Gate: No enterprise proposal expands beyond approved package, price floor, review owner, contract posture, and margin exposure.
• Workaround: Use non-binding readiness packets and qualified-review labels until counsel, accounting, tax, and finance reviewers approve templates.
• Hard stop: Do not imply audited financials, legal approval, tax advice, revenue guarantee, profit guarantee, securities material, or contract approval.

Abridge

• Hardening: Package every demo as a context-to-evidence-to-human-review operating loop with explicit no-live-care and no-PHI boundaries.
• Boundary: No copied clinical documentation models, no patient data, no customer-logo implication, and no clinical superiority claim.
• Proof: /competitive-intelligence

Ambience Healthcare

• Hardening: Create a no-PHI bake-off packet and route all time-saved, ROI, coding, and clinical-quality phrases through claim guard and qualified review.
• Boundary: No specialty performance, coding accuracy, reimbursement, or clinical quality claims without qualified external review.
• Proof: /qa-claim-guard

Nabla

• Hardening: Label every connector family as synthetic-ready, contract-ready, protected-gated, or blocked-live-use.
• Boundary: No production connector, EHR integration, API SLA, PHI authority, or customer deployment claim until buyer-approved contracts exist.
• Proof: /health-records

Suki

• Hardening: Add security-and-revenue adjacency controls to every sales packet and keep all ROI/security/certification claims in blocked-claim registers.
• Boundary: No trust-portal equivalence, EHR breadth claim, ROI guarantee, security certification, or clinical reasoning authority.
• Proof: /enterprise-business-ops

Microsoft Dragon Copilot

• Hardening: Make launch readiness, legal/privacy/cyber boundaries, buyer packet evidence, and workflow loops visible before every sales call.
• Boundary: No Microsoft partnership, Azure equivalence, platform-scale equivalence, Dragon parity, or managed-security implication.
• Proof: /launch-readiness

Claims and legal review firewall

• Owner: Legal operations and founder
• Evidence: /claims
• This is not legal advice or final approval; qualified counsel remains required for legal positions.

No-PHI default and minimum-necessary privacy path

• Owner: Privacy and interoperability
• Evidence: /health-records
• No PHI processing authority, HIPAA compliance certification, BAA execution, or live data approval is created by this control.

NIST CSF operating profile

• Owner: Security operations
• Evidence: /service-reliability
• This profile is readiness evidence only; it is not SOC 2, HITRUST, ISO, penetration-test, or managed-security certification.

LLM and agent threat model

• Owner: AI safety and TrustOS
• Evidence: /trust-os
• This is not a model-safety certification, live autonomous AI approval, or permission to process PHI.

Identity, AAL2, and secret hygiene

• Owner: Identity and workspace operations
• Evidence: /pilot-workspace/access
• No bypass of AAL2, no token minting by readiness pages, and no public secret storage.

Workflow Intelligence Assessment Delivery

• Window: 2 to 4 weeks
• Acceptance: All scoped workflows have owner, friction, evidence, and next action recorded, Buyer confirms no PHI or production credentials were provided, Recommendation is tied to a proof route and retained boundary
• Margin: Fixed fee, Capped workflow count, Change order for expanded mapping
• Operational intelligence only; no clinical advice, production automation, PHI processing, or guaranteed savings.

Health Records Safety Assessment Delivery

• Window: 2 to 5 weeks
• Acceptance: Every source type has a safety check and retained approval gate, Synthetic extraction path is separated from live-data path, Blocked actions are visible in the handoff
• Margin: Assessment excludes live connector build, Separate protected-pilot or connector SOW, Reusable extraction checklist
• No-PHI extraction planning only; patient matching, production connectors, writeback, payer submission, and clinical action remain blocked.

Interoperability Readiness Sprint Delivery

• Window: 30 to 45 days
• Acceptance: Every target standard has evidence route, owner, and gate, No live endpoint dependency exists inside sprint scope, Production connector approval is separated from readiness work
• Margin: Conformance templates reused, No custom live connector in sprint, Connector SOW priced separately
• Readiness and synthetic conformance only; production connector, PHI, security, privacy, and customer environment approval remain external gates.

TrustOS AI Governance Audit Delivery

• Window: 2 to 4 weeks
• Acceptance: Claims are classified as approved, evidence-required, or prohibited, Human review ownership is explicit, Legal, security, clinical, and regulatory conclusions are routed to qualified reviewers
• Margin: Repeatable TrustOS review pack, External review excluded unless scoped, Retainer path for continuous review
• Governance readiness only; legal, regulatory, security, certification, and clinical authority require qualified external review.

Buyer Discovery and No-PHI Intake

• Owner: Revenue Operations
• Hard stops: PHI in intake, No sponsor, Unsupported claim requested
• Proof: /client-onboarding, /offerings, /claims

Scope Matrix and Acceptance Plan

• Owner: Product Console
• Hard stops: Uncapped scope, No acceptance criteria, Contract-like commitment without review
• Proof: /service-delivery, /enterprise-business-ops, /operational-efficiency

Workflow and System Boundary Map

• Owner: Delivery Lead and Interoperability
• Hard stops: Live endpoint dependency, No owner for clinical or data gate, No workaround for blocked action
• Proof: /interoperability, /health-records, /limitations-workarounds

Inquiry Qualification

• Buyer outputs: Fit response, Discovery scheduling options, Safe proof route
• Internal outputs: Qualified lead note, Selected onboarding path, Initial disqualifier check
• Hard stops: PHI in intake, production credential shared, legal or clinical approval requested

Discovery Scheduling

• Buyer outputs: Calendar-ready description, Discovery agenda, Pre-call no-PHI note
• Internal outputs: Meeting owner, CRM-safe record, Follow-up SLA timer
• Hard stops: calendar invite without human approval, PHI or credentials in event body, unsupported promise in agenda

Demo Preparation

• Buyer outputs: Demo confirmation, Run-of-show, Proof route list
• Internal outputs: Demo script, Blocked-claim checklist, Follow-up packet plan
• Hard stops: live patient data requested, custom claim without evidence, customer reference implied without permission

Demo Follow-Up

• Buyer outputs: Recap email, Proof route links, Next-step recommendation
• Internal outputs: Opportunity update, Objection log, Pilot or diligence handoff
• Hard stops: ROI guarantee, clinical approval implied, unpriced custom work promised

Pilot Scoping

• Buyer outputs: Pilot scoping note, Workshop agenda, Decision criteria
• Internal outputs: Pilot package, Price floor, Diligence path, Required approvals
• Hard stops: PHI in pilot scope, production connector dependency, SOW or price commitment without review

Assessment Package

• Window: 2 to 4 weeks
• Includes: Workflow Intelligence Assessment, Health Records Safety Assessment, TrustOS AI Governance Audit
• Expansion: Synthetic Pilot Evaluation or Interoperability Readiness Sprint

Readiness Sprint Package

• Window: 30 to 45 days
• Includes: Interoperability Readiness Sprint, Clinical Operations Automation Blueprint, Global Certification Readiness Pack
• Expansion: Synthetic Pilot Evaluation or Enterprise Proof and Deal Room Activation

Synthetic Pilot Package

• Window: 45 to 90 days
• Includes: Synthetic Pilot Evaluation, TrustOS AI Governance Audit, Enterprise Proof and Deal Room Activation
• Expansion: Protected Enterprise Pilot or Enterprise Operating Layer License

Enterprise Activation Package

• Window: 90 to 180 days depending on buyer controls
• Includes: Enterprise Proof and Deal Room Activation, Clinical Operations Automation Blueprint, Enterprise Operating Layer License
• Expansion: Multi-year enterprise operating license or strategic platform partnership

Founder-led assessment sprint

• Health system operations, access, documentation, transformation, and revenue-cycle leaders
• No PHI, no live clinical execution, no savings guarantee, and no medical advice.
• Next: Run a weekly sponsor list, route qualified buyers to Pilot Intake, and package each call around one workflow pain plus one proof route.
• Proof routes: /pricing, /product, /demos, /pilot, /sales-operations

Synthetic Atlas pilot pipeline

• Enterprise sponsors ready to test governed workflow intelligence before integration
• Synthetic-only evidence until buyer-specific approvals, security review, and governance gates are retained.
• Next: Use the Deal Room to frame pilot scope, review team, synthetic packet, decision metric, and protected workspace path.
• Proof routes: /capital-vitality, /pilots, /pilot-deal-room, /evaluation

AI governance audit wedge

• Compliance, legal, privacy, security, clinical governance, and innovation leaders
• Readiness audit is not HIPAA certification, SOC 2 certification, HITRUST certification, legal approval, or FDA clearance.
• Next: Create counsel-reviewable sales language and keep every certification or regulatory phrase behind external-review gates.
• Proof routes: /approvals-readiness, /boundary-resolution, /qa-claim-guard, /trust-center

Protected buyer diligence upgrade

• Procurement, security, investor diligence, and executive buying committees
• External sharing stays blocked until release decisions, reviewer signoffs, recipient controls, access logs, and customer permission are retained.
• Next: Keep diligence packaging metadata-only until buyer-approved storage, access review, DLP, retention, and legal hold controls exist.
• Proof routes: /buyer-release-control-run, /pilot-workspace/access, /pilot-deal-room

Angel investors and early healthcare operators

• Packet: Category thesis, Founder-led sales plan, Synthetic pilot examples, Use-of-funds draft
• Review: Qualified securities counsel before solicitation, SAFE/equity note, valuation, or offering documents.
• Next: Run angel conversations through a counsel-reviewed deck and readiness-only data room before any offering language.
• Blocked: Guaranteed return, Investment recommendation, Approved securities offer, Valuation certainty

Large corporate strategic investors

• Packet: Strategic-fit memo, Integration boundary map, Deployment profile, Partner economics review
• Review: Qualified counsel, security, privacy, procurement, and finance review.
• Next: Prepare a non-binding strategic partnership memo before any exclusivity, reseller, integration, or data-rights term sheet.
• Blocked: Partnership approved, Exclusive rights granted, Production connector approved, Data rights assigned

Private investors and growth-equity reviewers

• Packet: KPI stack, Unit-economics assumptions, Pricing architecture, Deal-desk controls
• Review: Qualified finance/accounting/legal review before KPI, valuation, securities, revenue, or margin claims.
• Next: Move private investor review through finance-methodology and counsel-review packets before external metric claims.
• Blocked: Audited metrics, Guaranteed margin, Guaranteed revenue, Valuation assurance

Faith-based clinics and mission-led clinic investors

• Packet: Mission-fit brief, No-PHI clinic workflow assessment, Stewardship value map, Nonprofit/tax review checklist
• Review: Qualified nonprofit, tax, legal, privacy, and clinical governance review.
• Next: Offer a human-reviewed clinic discovery path and keep donor, nonprofit, grant, and tax language behind qualified review.
• Blocked: Tax-deductible investment, Religious endorsement, IRS approval, Donor outcome guarantee

Health system executives

• Packet: Workflow assessment scope, Synthetic pilot plan, Governance report, Implementation blueprint
• Review: Buyer clinical, privacy, security, legal, and implementation review before protected or live stages.
• Next: Route qualified sponsors into Pilot Intake and attach one workflow target, success metric, and review team.
• Blocked: Clinical outcome guaranteed, PHI approved, Production integration approved, Autonomous care

Synthetic Atlas Pilot

• Packaged as a premium fixed-fee pilot before any protected enterprise or production-license commitment.
• Pilot evidence remains synthetic or protected-evaluation only until buyer-specific live controls are approved.
• Proof routes: /product, /pilot-deal-room, /pilots, /pricing

Workflow Intelligence Assessment

• Fixed-scope assessment with clear upgrade path into Synthetic Atlas Pilot.
• Findings are operational intelligence for human leaders, not medical, legal, reimbursement, or accounting advice.
• Proof routes: /pricing, /product, /pilot, /sales-operations

AI Readiness + Governance Audit

• Assessment fee that can expand into protected pilot controls and enterprise diligence work.
• Readiness audit does not certify HIPAA, SOC 2, HITRUST, FDA, ONC, security posture, or legal compliance.
• Proof routes: /approvals-readiness, /boundary-resolution, /clinical-authority-readiness, /trust-center

Clinical Operations Automation Blueprint

• Strategy and implementation-planning package that precedes protected pilot or enterprise license.
• Blueprint remains review-only and does not authorize live clinical workflow execution or production connectors.
• Proof routes: /agents, /workflows, /healthcare-intelligence-os, /interoperability

Protected Buyer Diligence Rooms

• Bundled into enterprise pilot/procurement motion; future premium service when release authority is retained.
• External sharing remains blocked until release decisions, reviewer signoffs, recipient controls, and access-log reconciliation are retained.
• Proof routes: /pilot-workspace/access, /buyer-release-control-run, /pilot-deal-room

Investor narrative brief

• Proof: /api/capital-vitality/brief
• Brief is not securities offering material or investment advice.
• Next: Review with counsel before using in fundraising or investor solicitation.

Pilot conversion proof

• Proof: /pilot-deal-room, /pricing, /sales-operations, /attribution-analytics
• Conversion proof is operating evidence, not customer revenue guarantee.
• Next: Keep every opportunity source, buyer segment, offer, and next action tagged.

Unit economics and board metrics

• Proof: /public-market-readiness and /pilot-workspace/access
• Protected metrics are not audited financial statements.
• Next: Use AAL2 protected capture for real operating metrics and preserve methodology notes.

Security and compliance review packet

• Proof: /approvals-readiness and /pilot-workspace/access
• Readiness packet is not security certification or legal approval.
• Next: Retain qualified reviewers before enterprise assurance language expands.

Product Console and OS Hub discoverability

• Owner: Product Console + Release Steward
• Proof routes: /product, /hub, /navigation, /api/navigation-audit
• Route discoverability is operating evidence, not protected execution proof or release approval.

Release continuity and source-control alignment

• Owner: Release Steward
• Proof routes: /release-continuity, /api/release-continuity, /api/release-continuity/brief
• Continuity proof does not mint tokens, store secrets, bypass AAL2, or approve buyer release.

Clinical, legal, security, and approval authority

• Owner: Founder + qualified external reviewers
• Proof routes: /approvals-readiness, /clinical-authority-readiness, /boundary-resolution, /qa-claim-guard
• Qualified counsel, security assessors, regulatory experts, customer approvers, and applicable certification bodies retain authority.

Manual AAL2 protected proof

• Owner: Approved tenant-admin or pilot-lead operator
• Proof routes: /pilot-workspace/access, /qa-manual-execution-console, /qa-run-control, /qa-human-run-packet, /buyer-release-control-run
• No code path may retain, print, store, or reuse bearer tokens; protected happy path proof stays human-operated.

Buyer release and external sharing

• Owner: Buyer Diligence + Release Steward + qualified reviewers
• Proof routes: /buyer-release-control-run, /pilot-workspace/access#buyer-release-control-verifier, /api/pilot-workspaces/{workspaceSlug}/buyer-release-control-run
• Internal protected diligence can prepare evidence; external buyer sharing remains blocked until qualified release authority is retained.

Commercial buyer path

• Owner: Sales operations + Buyer Diligence
• Proof routes: /pilot-deal-room, /pricing, /demos, /pilots, /sales-operations
• Commercial readiness does not authorize customer production activation, PHI, live clinical execution, or public customer claims.

Multi-tenant runtime capacity

• Control: Capacity forecasts, load-test targets, route-level owner assignment, queue thresholds, and fail-closed paths are attached to every enterprise release.
• Boundary: Capacity readiness is not contractual uptime, production throughput approval, or managed service coverage.
• Proof routes: /navigation, /service-reliability, /release-continuity

Tenant isolation and data boundaries

• Control: Tenant role maps, no-PHI intake rules, protected workspace checks, RLS expectations, evidence-room references, and customer authority owners stay explicit.
• Boundary: Tenant isolation planning is not customer-specific tenancy approval, PHI processing authority, or security certification.
• Proof routes: /pilot-workspace/access, /clinical-authority-readiness, /boundary-resolution

Queueing, backpressure, and retry governance

• Control: Idempotency design, retry ceilings, dead-letter routing, duplicate-proof detection, and manual remediation gates remain part of the release path.
• Boundary: Queue readiness does not authorize autonomous remediation, production workflow execution, or live connector use.
• Proof routes: /workflows/execution-attempts, /workflows/runtime-safety, /qa-manual-execution-console, /qa-completion-bridge

Observability, SLO readiness, and error budgets

• Control: SLO candidates, error-budget language, alert routing, regression checks, incident learning, and buyer-safe boundary headers are tracked without SLA guarantees.
• Boundary: SLO readiness is internal operating discipline only; no contractual SLA or production support guarantee is created.
• Proof routes: /service-reliability, /continuous-review-audit, /operational-efficiency

Incident, problem, and change operations

• Control: Severity classes, incident owners, change windows, rollback paths, postmortem evidence, and claims updates are linked to review and release routes.
• Boundary: Incident readiness is not 24/7 production staffing, managed SOC or MDR coverage, or production remediation authority.
• Proof routes: /trust-safety-operations, /release-continuity, /boundary-resolution, /continuous-review-audit

Enterprise demand outruns scale proof

• Workaround: Use capped synthetic pilots, volume assumptions, route-class reviews, and scale preflight packs before any production wording.
• Gate: Load-test evidence, capacity plan, support tier, rollback plan, and qualified contract review.

Internal SLO language becomes buyer SLA language

• Workaround: Keep SLO language internal, label external materials as readiness-only, and route SLA wording to counsel and finance.
• Gate: Approved contract terms, support coverage, measurement method, and retained authority.

Tenant scale increases support load

• Workaround: Attach support assumptions, paid diligence packaging, escalation paths, and renewal health packets to enterprise accounts.
• Gate: Support tier approval, price-floor review, response target review, and customer-specific cadence.

API contract productization

• Control: Route handlers, status headers, typed summaries, markdown briefs, route inventory, smoke tests, and future OpenAPI/SDK handoff stay aligned.
• Boundary: Contract readiness is not a public API SLA, external API marketplace launch, or production integration approval.
• Proof routes: /navigation, /product, /api/product/console

Secure tenant API plane

• Control: Every tenant-facing path retains fail-closed checks, no-PHI rules, owner assignment, access review cadence, and protected workspace routing.
• Boundary: Tenant API planning does not approve PHI processing, customer-specific tenancy, production credentials, or live connector use.
• Proof routes: /pilot-workspace/access, /clinical-authority-readiness, /boundary-resolution

Rate limit, idempotency, and resilience

• Control: Idempotency keys, retry ceilings, throttling posture, duplicate-proof checks, dead-letter ownership, and fail-closed responses are required before scale claims.
• Boundary: Resilience design does not create contractual uptime, unlimited throughput, or autonomous production remediation.
• Proof routes: /workflows/execution-attempts, /workflows/runtime-safety, /service-reliability, /qa-manual-execution-console

Operator-grade UI command surfaces

• Control: Homepage actions, hub console views, product summary cards, role journeys, limitation controls, and proof-stack sections stay cross-linked.
• Boundary: UI command readiness is not accessibility certification, buyer training completion, or customer approval.
• Proof routes: /, /hub, /product, /navigation

Design system, accessibility, and performance readiness

• Control: Route pages use stable sections, table rows, summary metrics, constrained copy, and smoke-visible navigation while accessibility review remains explicit.
• Boundary: Accessibility and performance readiness is not a WCAG audit, VPAT, Section 508 conformance claim, or external UX certification.
• Proof routes: /navigation, /product, /hub

API contracts are typed but not yet exported as OpenAPI or SDKs

• Workaround: Use route summaries, smoke-tested JSON, boundary headers, and markdown briefs as the interim contract packet.
• Gate: OpenAPI spec, examples, auth model, rate limits, SDK backlog, version policy, and developer docs are reviewed.

Live AI model execution remains intentionally gated

• Workaround: Use deterministic synthetic summaries, model-route registers, eval design, TrustOS checks, and human approval packets.
• Gate: Approved model provider, allowed data class, eval pass criteria, monitoring, human approval flow, and customer-specific authority exist.

Accessibility certification is not complete

• Workaround: Run manual UI quality checks, keep layouts stable, avoid text overlap, expose role navigation, and retain accessibility review as a named gate.
• Gate: Qualified accessibility review, remediation evidence, VPAT or equivalent artifact, and approved external claims.

PHI and live patient-data boundary

• Workaround: Use synthetic fixtures, metadata-only references, external evidence-room pointers, no-PHI excerpts, and Health Records Safety Exchange source mapping.
• Gate: Executed customer authority, BAA/DPA when required, security review, clinical governance approval, connector approval, monitoring, rollback, and retained evidence.
• Proof routes: /health-records, /clinical-authority-readiness, /boundary-resolution

Live clinical care and CDS authority

• Workaround: Frame outputs as synthetic workflow planning, review queues, draft-only documentation, and clinical-governance preparation with explicit human review.
• Gate: Clinical governance approval, regulatory classification, customer scope, clinician workflow controls, monitoring, override, and rollback evidence.
• Proof routes: /clinical-authority-readiness, /clinical-care-activation, /qa-claim-guard

Production EHR connector and writeback boundary

• Workaround: Use fixture validation, synthetic conformance kits, connector contract review, external artifact references, and no-mutation evidence.
• Gate: Customer sandbox, security review, connector contract, data boundary approval, mutation policy, audit, monitoring, and rollback evidence.
• Proof routes: /interoperability, /health-records, /integrations/fixture-validation

Public API, SLA, and unlimited-scale boundary

• Workaround: Use route summaries, boundary headers, version posture, draft quotas, rate-limit classes, support assumptions, and no-SLA language.
• Gate: Contract terms, staffing model, support tier, incident response, monitoring, rate limits, price model, and executive approval.
• Proof routes: /platform-power, /enterprise-scalability, /service-reliability

Live AI, production model-routing, and agent autonomy boundary

• Workaround: Use model-route registers, allowed/blocked data classes, eval packs, red-team loops, human approval triggers, and protected AAL2 operator lanes.
• Gate: Approved provider, model route, data policy, eval pass criteria, monitoring, tool schema, approval UI, rollback, audit persistence, and customer authority.
• Proof routes: /agents, /trust-os, /platform-power, /continuous-review-audit

Security, privacy, SOC 2, HITRUST, and certification boundary

• Workaround: Use Trust Center, Provider Security Reviews, Procurement Evidence Registry, Global Certification Readiness, and no-sensitive-artifact references.
• Gate: Qualified assessment, remediation evidence, approved artifact reference, customer-specific acceptance, and release authority.
• Proof routes: /trust-center, /global-certification-readiness, /pilot-workspace/access

Synthetic no-PHI packet

• Output: Buyer-safe demo or assessment packet with explicit no-PHI and no-live-care boundary.
• Expiry: Refresh whenever source class, buyer scope, approval state, or claim language changes.

External evidence reference

• Output: Metadata-only reference that points to the authority source without storing the underlying artifact.
• Expiry: Renew before expiration, owner change, buyer scope change, or regulation/certification scope change.

Human-reviewed communication packet

• Output: Draft-only communication with approval slot, send owner, follow-up owner, and blocked-content checklist.
• Expiry: Re-review after 7 days, pricing change, scope change, reviewer change, or new buyer requirement.

AAL2 protected proof packet

• Output: Protected no-secret proof packet with release decision and buyer-safe claim state.
• Expiry: Re-run when deployment, route, workspace, reviewer, claim language, or evidence packet changes.

SCRIMED has a protected operator console for human AAL2 synthetic QA execution, but no buyer proof or production authority exists until retained no-secret packet evidence and Buyer Proof Release pass.

• Protected workspace anchor: /pilot-workspace/access#manual-qa-execution-console
• Buyer proof ready: no

Fresh human AAL2 operator session

• Open the protected workspace with a fresh AAL2 session before dispatch.

Manual workflow dispatched against one synthetic target

• Use the Human Run Packet command template and one explicit synthetic target.

Temporary secret deleted or rotated

• Delete or rotate temporary token material before packet persistence.

No-secret metadata captured

• Persist only safe IDs, timestamps, run URL, packet audit UUID, and fixed attestations.

Append-only audit signal visible

• Refresh protected audit events after packet persistence.

Buyer Proof Release passed

• Complete the human AAL2 run, persist no-secret metadata, then verify Proof Promotion, Activation Seal, Claim Guard, and this release gate before Buyer Diligence export.

SCRIMED remains activation-ready; retained manual AAL2 QA proof cannot be used in buyer diligence until the protected release gate passes.

• Protected route: /api/pilot-workspaces/{workspaceSlug}/qa-evidence/buyer-proof-release
• Buyer packet: /api/pilot-workspaces/{workspaceSlug}/buyer-room/packet
• Public release: blocked

Retained protected packet visible

Proof Promotion permits buyer diligence

Activation Seal allows buyer use

Claim Guard keeps language bounded

External authority remains separately gated

internal-only-until-release-chain-retained

• Steps: 8
• Protected routes: 8
• Packet routes: 8
• Verifier: /api/pilot-workspaces/{workspaceSlug}/buyer-release-control-run
• Verifier packet: /api/pilot-workspaces/{workspaceSlug}/buyer-release-control-run/packet
• Timeline: /api/pilot-workspaces/{workspaceSlug}/buyer-release-control-run/timeline
• Hard stops: 42

Reference externally retained approval evidence

• Packet: /api/pilot-workspaces/{workspaceSlug}/external-approval-evidence/packet
• append-only approval-reference packet audit event

Record versioned release decision candidate

• Packet: /api/pilot-workspaces/{workspaceSlug}/release-decisions/packet
• versioned release-decision audit event

Capture named reviewer signoff metadata

• Packet: /api/pilot-workspaces/{workspaceSlug}/reviewer-signoffs/packet
• reviewer-signoff packet audit event

Record disabled distribution lockbox

• Packet: /api/pilot-workspaces/{workspaceSlug}/distribution-lockbox/packet
• disabled lockbox packet audit event

Live clinical care authority

• Sell synthetic pilot evaluation, workflow intelligence assessment, and draft-only clinician-reviewed planning.
• Proof routes: /clinical-care-activation, /pilot-workspace/access, /trust-os

PHI and ePHI processing authority

• Use synthetic fixtures, de-identified data only when contract-approved, and no-sensitive-artifact evidence links.
• Proof routes: /trust-center, /public-market-readiness, /pilot-workspace/access

Legal approval and contracting authority

• Use controlled buyer packets with explicit boundaries and no public customer or certification claims.
• Proof routes: /trust-center, /public-market-readiness, /global-reach

Regional regulatory approval

• Run synthetic executive evaluations and partner qualification without live data, public authority claims, or production integrations.
• Proof routes: /global-reach, /deployment-profiles, /market-activation

Reimbursement, coverage, coding, and payer policy approval

• Deliver denial-risk review, prior-authorization packet drafting, and revenue leakage analysis as human-reviewed draft support.
• Proof routes: /public-market-readiness, /pricing, /pilot-deal-room

1. Human AAL2 session

• Accepted: operator role, workspace slug, AAL2 session timestamp
• This confirms operator context only; it is not clinical, legal, security, reimbursement, or production authorization.

2. Explicit synthetic target

• Accepted: workflow kind, intake ID or workspace slug, base URL
• Targets must remain synthetic or no-PHI metadata-only. No patient, payer member, EHR, source contract, or production connector target is allowed.

3. Token preflight

• Accepted: preflight pass/fail, token lifetime policy status, target confirmation
• Preflight is only a local safety gate. Protected SCRIMED APIs and Supabase Auth remain the verification authority.

4. Authenticated smoke

• Accepted: workflow run ID, workflow run URL, created synthetic object ID, packet audit event ID
• A passing authenticated smoke proves the synthetic protected route only. It does not authorize live care or PHI workflows.

5. Secret disposal

• Accepted: token disposal attestation, temporary secret name, disposal timestamp
• The token itself is never evidence and must never be copied into SCRIMED, source control, docs, logs, packets, or runtime configuration.

Sales Demo Session QA activation

• Temporary secret: SCRIMED_SALES_QA_BEARER_TOKEN
• Command templates: 2
• Evidence route: /api/qa-evidence/manual-run-packet
• Persistence: /api/pilot-workspaces/{workspaceSlug}/qa-evidence/manual-run-packets

Authority Reference QA activation

• Temporary secret: SCRIMED_BEARER_TOKEN
• Command templates: 2
• Evidence route: /api/qa-evidence/manual-run-packet
• Persistence: /api/pilot-workspaces/{workspaceSlug}/qa-evidence/manual-run-packets

Confirm human AAL2 session

• Pass: The operator has an approved tenant role and current AAL2 browser session.
• Fail closed: The session is stale, shared, missing AAL2, or scoped to the wrong tenant.

Select exactly one synthetic target

• Pass: The target is explicit, synthetic, and contains no PHI, payer member data, or production data.
• Fail closed: The target is missing, broad, production-linked, or contains regulated data.

Create temporary masked workflow secret

• Pass: The token is short-lived, masked, workflow-specific, and never pasted into source, docs, chat, or packets.
• Fail closed: The token is long-lived, copied into evidence, or stored anywhere outside the temporary secret path.

Run preflight and dispatch

• Pass: Preflight passes and the manual workflow completes against the explicit synthetic target.
• Fail closed: Preflight fails, authenticated path is optional, the target changes, or the workflow is scheduled.

Copy safe metadata only

• Pass: No token, credential, PHI, artifact URL, source contract, clinical record, or approval artifact enters SCRIMED evidence.
• Fail closed: Any evidence field contains secret-like material or regulated identifiers.

Approved human operator

• Fail closed: The session is stale, shared, non-AAL2, or the role is not allowed.

Single synthetic target

• Fail closed: The target is broad, production-linked, patient-linked, payer-member-linked, or ambiguous.

Manual workflow only

• Fail closed: The workflow is scheduled, unattended, or allows the authenticated path to be optional.

No-secret evidence fields

• Fail closed: Tokens, credentials, PHI, payer member data, legal artifacts, reports, contracts, or clinical records appear.

Protected packet visibility

• Fail closed: Only a public packet preview, operator assertion, screenshot, or chat statement exists.

Proof and claim gates

• Fail closed: Any buyer, investor, sales, PR, or operator language claims retained proof or production authority too early.

Clinical authority blocked

• Fail closed: The packet is used as clinical care, PHI, payer submission, reimbursement, certification, connector, or regional approval.

Human AAL2 workflow run

• Pass: The candidate payload references exactly one completed human-run synthetic workflow.
• Fail closed: The run did not happen, was scheduled/unattended, used a broad target, or references regulated data.

No-secret candidate validation

• Pass: The public bridge returns ready-for-protected-persistence and a packet preview SHA-256.
• Fail closed: The payload contains bearer/JWT-like material, PHI, payer member data, credentials, invalid attestations, or unsupported workflow kind.

Protected packet persistence

• Pass: The protected workspace returns a retained packet hash and append-only audit event.
• Fail closed: The operator lacks AAL2 governance authorization or the protected write rejects the payload.

Proof Promotion decision

• Pass: Proof Promotion moves buyer language from activation-ready to retained no-secret QA evidence.
• Fail closed: Buyer material claims authenticated proof before protected packet hash visibility.

Clinical and production authority

• Pass: Authority remains explicitly blocked unless external approvals exist.
• Fail closed: Anyone treats QA completion evidence as PHI, live-care, payer, connector, security-certification, or reimbursement authorization.

Current-state language only

• SCRIMED has a governed no-secret synthetic QA readiness path with human AAL2 gates still explicit.

Retained packet language requires packet hash

• SCRIMED has an activation-ready path; retained authenticated QA proof will be referenced only after protected packet hash visibility.

Clinical and production authority remain blocked

• SCRIMED is currently positioned for governed synthetic pilots and enterprise evaluation; production clinical authority remains separately gated.

External-use claims need qualified review

• Use internal diligence language until the required external-use approval packet is retained.

SCRIMED has a no-secret activation path, but the QA Activation Seal remains unsealed until protected packet evidence is visible.

• Buyer use: no
• Required evidence: 10
• Hard stops: 4

Protected packet required

• Fail closed: Only a public preview hash or operator assertion is available.

Audit event required

• Fail closed: The audit event is missing, synthetic target is ambiguous, or IDs do not match.

No secrets or PHI

• Fail closed: Any field contains secret-like, PHI-like, credential-like, or regulated identifiers.

Proof Promotion decision required

• Fail closed: Proof Promotion is pending, under review, or not visible.

Claim Guard required

• Fail closed: Language implies legal approval, certification, live clinical care, PHI authority, reimbursement certainty, or connector approval.

Human AAL2 provenance required

• Fail closed: The workflow was unattended, scheduled, broad-targeted, or token disposal is not attested.

Clinical and production authority blocked

• Fail closed: Anyone treats QA evidence as clinical, PHI, payer, reimbursement, certification, connector, or production authorization.

SCRIMED has an operator-ready manual AAL2 QA path, but retained authenticated QA proof is still pending.

• Promotion allowed: no
• Hard stops: 3
• Blocked claims: 9

Retained packet hash required

• No hash means no retained authenticated QA proof claim.

No-secret evidence only

• The token itself is never evidence.

Human AAL2 provenance required

• AAL2 provenance is not clinical, legal, reimbursement, or production authorization.

Buyer Diligence export after persistence

• Buyer proof is limited to governed synthetic QA evidence.

Clinical and production claims remain blocked

• Retained QA proof improves diligence; it does not unlock production clinical execution.

Live clinical care authority

• Sell synthetic pilot evaluation, workflow intelligence assessment, and draft-only clinician-reviewed planning.
• Proof routes: /clinical-care-activation, /pilot-workspace/access, /trust-os

PHI and ePHI processing authority

• Use synthetic fixtures, de-identified data only when contract-approved, and no-sensitive-artifact evidence links.
• Proof routes: /trust-center, /public-market-readiness, /pilot-workspace/access

Legal approval and contracting authority

• Use controlled buyer packets with explicit boundaries and no public customer or certification claims.
• Proof routes: /trust-center, /public-market-readiness, /global-reach

Regional regulatory approval

• Run synthetic executive evaluations and partner qualification without live data, public authority claims, or production integrations.
• Proof routes: /global-reach, /deployment-profiles, /market-activation

Reimbursement, coverage, coding, and payer policy approval

• Deliver denial-risk review, prior-authorization packet drafting, and revenue leakage analysis as human-reviewed draft support.
• Proof routes: /public-market-readiness, /pricing, /pilot-deal-room

Is SCRIMED structurally, product-wise, service-wise, and functionally ready to launch without confusing sandbox DNS with app failure?

• /product
• /release-continuity
• /operations
• /navigation
• /service-reliability
• /limitations-workarounds
• /pilot-workspace/access
• Launch readiness does not approve launch, bypass sandbox restrictions, create contractual SLAs, authorize PHI, approve connectors, certify compliance, approve customer release, or authorize live clinical care.

Can SCRIMED turn fragmented workflows into governed operational intelligence?

• /pilot-evidence
• /service-reliability
• /demos
• /pilots
• /pricing
• Evaluation remains synthetic and review-gated; no autonomous diagnosis, patient routing, payer submission, or live care.

Can SCRIMED pass enterprise diligence without exposing sensitive artifacts?

• /trust-center
• /public-market-readiness
• /pilot-workspace/access
• /trust-safety-operations
• Readiness metadata is not security approval, legal advice, compliance certification, executed BAA/DPA, or production authorization.

Can SCRIMED harden against competitors and infiltrations without creating legal, privacy, or cybersecurity overclaims?

• /claims
• /trust-center
• /global-certification-readiness
• /health-records
• /platform-power
• /trust-os
• /release-continuity
• Competitive defense is readiness only; it is not legal advice, privacy approval, security certification, penetration-test authorization, competitor partnership, protection guarantee, PHI authority, or live-care authority.

How does SCRIMED keep reviewing accuracy, reducing mistakes, and researching future infrastructure around the clock?

• /qa-evidence
• /source-intelligence
• /trust-safety-operations
• /global-certification-readiness
• /service-reliability
• Agent-assisted review does not replace qualified human approval, managed SOC/MDR coverage, legal review, clinical review, certification, or production remediation authority.

Which gaps, inefficiencies, bottlenecks, and hard stops should SCRIMED resolve first?

• /limitations-workarounds
• /service-reliability
• /enterprise-scalability
• /navigation
• /release-continuity
• /growth-engine
• /enterprise-business-ops
• /continuous-review-audit
• /boundary-resolution
• Operational efficiency routing is execution discipline only; it is not autonomous remediation, AAL2 bypass, PHI authority, certification, legal/accounting/tax advice, revenue guarantee, profit guarantee, buyer release approval, or clinical authority.

A request is blocked. What can SCRIMED safely do today?

• /boundary-resolution
• /operational-efficiency
• /platform-power
• /client-onboarding
• /health-records
• /qa-claim-guard
• Workaround ownership is containment only; it does not create approval, certification, PHI authority, clinical authority, legal/finance advice, live AI authority, public SLA, or buyer release.

Is the production release checkpointed, smoke-tested, and safely bounded for protected proof?

• /navigation
• /release-continuity
• /product
• /pilot-workspace/access
• /buyer-release-control-run
• /qa-run-control
• Navigation and release continuity are operational evidence only; protected happy-path proof still requires an approved human AAL2 session and no token storage.

Is SCRIMED building defensible healthcare intelligence infrastructure with a clear audience-specific capital story?

• /capital-vitality
• /enterprise-business-ops
• /public-market-readiness
• /competitive-edge
• /market-activation
• /pilot-deal-room
• Investor materials are operating-readiness evidence, not audited financial reporting, securities offering material, solicitation, valuation assurance, legal advice, tax advice, or investment advice.

Can SCRIMED support clinic stewardship, access, and workflow capacity without overclaiming nonprofit, donor, or clinical authority?

• /faithcore
• /client-onboarding
• /market-activation
• /health-records
• /limitations-workarounds
• /qa-claim-guard
• Faith-based clinic readiness is not donor advice, tax advice, charitable approval, religious endorsement, PHI authority, production connector approval, reimbursement assurance, or live clinical authority.

Can SCRIMED manage enterprise deals, margins, contracts, tax/accounting review, and cash discipline at scale?

• /enterprise-scalability
• /growth-engine
• /sales-operations
• /public-market-readiness
• /capital-vitality
• /pilot-deal-room
• Business operations evidence is not legal advice, accounting advice, tax advice, audited financial reporting, contract approval, revenue guarantee, profit-margin guarantee, securities material, or customer permission.

Can SCRIMED scale tenants, support, reliability evidence, incident response, regional deployment, and cost controls without overcommitting?

• /platform-power
• /service-reliability
• /release-continuity
• /client-onboarding
• /enterprise-business-ops
• /operational-efficiency
• /global-certification-readiness
• Enterprise scale readiness is not a contractual SLA, uptime guarantee, managed service commitment, production support guarantee, security certification, PHI authority, production connector approval, revenue guarantee, or profit-margin guarantee.

Can SCRIMED make its API, UI, and AI platform feel enterprise-grade without overclaiming live authority?

• /agents
• /trust-os
• /navigation
• /service-reliability
• /continuous-review-audit
• /boundary-resolution
• /enterprise-scalability
• Platform power readiness is not public API SLA approval, live autonomous AI approval, production model routing, PHI processing, EHR access, accessibility certification, security certification, or trillion-dollar-scale equivalence.

How does SCRIMED move from demos toward controlled clinical operations safely?

• /clinical-care-activation
• /healthcare-intelligence-os
• /agents
• /workflows
• /interoperability
• Clinical authority readiness is a gated preparation layer; it does not authorize PHI ingestion, treatment decisions, EHR mutation, reimbursement claims, certification claims, or autonomous clinical execution.

Which approvals, certifications, region, buyer pack, and procurement path must SCRIMED prepare for?

• /global-reach
• /deployment-profiles
• /market-activation
• /pilot-deal-room
• /trust-center
• Global Certification Readiness and Global Reach are preparation layers only; they are not legal advice, regional regulatory approval, procurement approval, compliance certification, conformity, PHI authority, or production clinical authority.

Provider and health-system executives

• Provider buyers see a full operating layer: AgentOS, TrustOS, interoperability, protected workspaces, proof packets, and clinical activation gates.
• Disqualifiers: Requests autonomous diagnosis, Requires live PHI in public intake, Wants immediate EHR writeback without governance

Payers, plans, and revenue-cycle leaders

• Payer and RCM buyers get review-gated evidence, cost-per-workflow discipline, policy attribution, and finance methodology boundaries.
• Disqualifiers: Requests reimbursement guarantee, Requires payer submission automation before approval, Asks SCRIMED to make coverage determinations

Government and public-sector healthcare leaders

• Public-sector buyers see sovereign deployment optionality, governance-first evaluation, region packs, and public-claim controls.
• Disqualifiers: Requests government approval claim before authorization, Requires public health reporting before implementation review, Needs live citizen data in evaluation

Life sciences, research networks, oncology programs, and trial operations

• Research buyers get evidence trails, eligibility rationale, missing-data prompts, and explicit no-enrollment boundaries.
• Disqualifiers: Requests patient enrollment action, Requires treatment recommendation, Bypasses research governance or ethics review

Employers and benefits leaders

• Employer buyers see a privacy-first path to workflow and care-navigation intelligence without becoming a medical decision-maker.
• Disqualifiers: Requests employee diagnosis, Requires member data before agreements, Wants patient outreach without consent

International draw

• Risk: Regional counsel, procurement, privacy, and public-sector authority are still external-review gates.
• Next: Package the top launch and strategic regions into localized no-PHI outreach packets.

Global interoperability

• Risk: Live connectors, profile selection, licensing, regional exchange participation, and writeback remain blocked.
• Next: Attach regional interoperability lanes to deployment profiles and buyer diligence packets.

Global communication

• Risk: External communications, translations, partner claims, pricing, legal language, and clinical statements require review.
• Next: Use the communication lanes for every regional buyer, partner, investor, and public-sector conversation.

Global assurance

• Risk: No certification, regulatory approval, public-sector procurement approval, or clinical validation claim is authorized.
• Next: Create evidence-room packets for the regions with the strongest commercial pull.

United States

• Sales motion: Direct enterprise sales supported by advisors, implementation partners, provider champions, and payer innovation teams.
• Retained gates: signed enterprise scope, BAA/DPA where applicable, security review, clinical governance review, production connector approval
• Proof: /product, /pilot-deal-room, /public-market-readiness, /trust-center

UAE

• Sales motion: Strategic partnership and government-facing channel qualification before public claims or national-program positioning.
• Retained gates: regional counsel review, hosting and residency approval, public-sector procurement process, qualified local implementation partner, translation and claims review
• Proof: /deployment-profiles, /global-reach, /governance-packs, /trust-center

Saudi Arabia

• Sales motion: Executive partnership route through qualified regional advisors, implementation partners, and public-sector relationship holders.
• Retained gates: regional counsel review, government procurement authority, data-residency approval, cybersecurity review, partner authority validation
• Proof: /global-reach, /deployment-profiles, /healthcare-intelligence-os, /trust-safety-operations

Kuwait

• Sales motion: Qualified local partner discovery with controlled outreach and no public customer or government approval claims.
• Retained gates: qualified local partner, regional counsel review, buyer procurement process, data residency decision, customer go-live approval
• Proof: /global-reach, /pilot-evidence, /trust-center, /pricing

Nigeria

• Sales motion: Blend direct founder-led relationships with channel partners, health entrepreneurs, faith-aligned institutions, and training partners.
• Retained gates: local privacy review, public-sector authority where applicable, customer data-processing agreement, clinical governance reviewer, production support model
• Proof: /global-reach, /faithcore, /market-activation, /pilots

Healthcare Intelligence Infrastructure

Does not claim autonomous clinical execution or replacement of healthcare professionals.

Trust-First Enterprise Proof

Does not claim HIPAA certification, SOC 2 certification, FDA clearance, or production authorization.

Interoperability Sidecar Strategy

Does not claim certified live connector status or production EHR writeback during synthetic pilots.

Evidence-To-Revenue Motion

Does not guarantee savings, reimbursement, denial reduction, or clinical outcomes.

FaithCore And Atlas Trust Positioning

Does not mix spiritual support with diagnosis, treatment, emergency triage, or clinical authority.

Global Deployment Optionality

Does not claim region-specific compliance approval until legal, privacy, security, and customer deployment review are complete.

What is SCRIMED and why is it differentiated?

Public education only; no buyer data or clinical claims required.

Can the product show governed workflow value before live data?

Synthetic scenarios only; no PHI or patient-facing execution.

Can my organization scope a paid assessment or synthetic pilot?

Business-contact and workflow-scope intake only.

Can SCRIMED manage opportunity ownership and next steps?

AAL2 tenant-admin access required; no direct table mutation.

Can we inspect tenant-scoped proof and limitations before paying for more scope?

Protected tenant workspace; synthetic-only, write-before-release artifacts.

What commercial step should we approve next?

Final scope, legal terms, security review, and production permissions require written approval.

24/7 trust, safety, monitoring, auditing, fixing, improving, and escalation model is defined. Production managed monitoring still requires approved staffing, on-call, SOC/MDR, and customer-specific runbooks before being claimed as live coverage.

• Agents: 7
• Controls: 5
• Tenant dashboard: /api/pilot-workspaces/{workspaceSlug}/trust-safety-incidents
• Tenant packet: /api/pilot-workspaces/{workspaceSlug}/trust-safety-incidents/{incidentId}/review-packet
• Incident reports: 6
• Open issues: 6
• Channels: 5
• Next: Apply and verify the tenant TrustOps Supabase migration in production, then add an authenticated workspace UI panel for incident creation, update, legal-hold review, notification decision, and packet download.

PHI-style intake content attempted in a public or sales workflow

• Owner: Privacy and product control owner
• Agent: PHI Shield Agent

Unsupported public claim, sales claim, or advertising claim needs substantiation

• Owner: Claims, marketing, legal, and product owner
• Agent: Claims And Legal Guard

Copyright, trademark, or third-party asset provenance missing before external use

• Owner: Brand, product, founder, and qualified IP counsel
• Agent: Copyright And IP Sentinel

Attribution analytics packet needed a dedicated audit event instead of CRM-export workaround

• Owner: Sales operations and audit persistence owner
• Agent: Continuous Improvement Agent

Tenant TrustOps incident workspaces turn trust into buyer-inspectable evidence.

• Private-schema incident tables
• RLS deny-all defense in depth
• AAL2 tenant-admin or pilot-lead mutation gates
• Tenant reviewer packet release with write-before-release audit
• Legal-hold and notification-decision fields

CIOs and digital transformation leaders

CISOs, security reviewers, and privacy officers

Compliance, legal, and governance teams

synthetic-public-fixture

• Records: 6
• Cohorts: 25
• Source coverage: 100%
• Proof coverage: 100%
• Protected API: /api/sales-operations/attribution-analytics

sourceCategory: campaign-attributed

offer: Workflow Intelligence Assessment

deploymentProfile: Managed Cloud Pilot Profile

deploymentProfile: Sovereign Cloud And Public Sector Profile

Current: governed synthetic evaluation

• Product Console proof stack
• QA evidence ledger
• Buyer Diligence Export
• Clinical activation readiness brief

Shadow-mode clinical readiness

• BAA/DPA or non-PHI determination
• Customer data-flow approval
• Clinician reviewer rubric
• Connector sandbox acceptance

Clinician-supervised prospective pilot

• Clinical safety case
• Licensed sign-off
• Patient communication policy where applicable
• Incident response and rollback plan

Limited production go-live

• Production go-live packet
• Connector conformance
• Monitoring dashboard
• Support and rollback coverage

Synthetic Pilot Evaluation

• Source: campaign-attributed
• Audience: Payer and revenue cycle leaders
• Deployment: Managed Cloud Pilot Profile
• Cadence: two business days

HL7 FHIR

• Attach deployment-profile and workflow metadata to FHIR, HL7 v2, DICOMweb, X12, IHE, and terminology targets.
• Interoperability readiness is synthetic and contractual until EHR, device, payer, customer, legal, privacy, and security approvals are completed.

Notion

• Add source-aware attribution and cadence so every buyer intake becomes a retained operating object.
• Workspace intelligence may organize business and workflow context, but it must not collect PHI through public intake or replace clinical review.

Figma Release Notes

• Retain source-intelligence plans for major product surfaces.
• Design and planning controls improve product quality; they do not create legal, clinical, privacy, or compliance approval.

Cursor

• Treat every strategic build as a work order with context, plan, changes, tests, deployment, and rollback notes.
• Build agents can accelerate engineering, but production healthcare workflows still require human review, audit, security, and clinical governance.

Hugging Face

• Keep model-provider routing abstracted from product workflows.
• Model availability does not authorize PHI processing, medical advice, autonomous care, or clinical validation.

Workflow Intelligence Assessment

• Official website -> Product Console -> Pilot Intake -> Sales Operations -> assessment invitation.
• Do not request PHI. Do not promise savings. Frame findings as operational intelligence for human leaders.

Synthetic Pilot Evaluation

• Demo Center -> Pilot Program -> no-PHI intake -> governance pack -> protected workspace planning.
• Synthetic data only. No diagnosis, treatment, payer submission, or patient outreach. Pilot metrics are directional business evidence.

Protected Enterprise Pilot

• Synthetic pilot proof -> security/legal/privacy review -> protected workspace -> enterprise license proposal.
• Requires legal, privacy, security, and governance review. Live PHI requires written approval and appropriate agreements. Human review remains required.

Annual Healthcare Intelligence OS License

• Protected pilot -> value review -> deployment profile -> annual license -> expansion roadmap.
• Separate platform license from implementation services. Scope workflows, connectors, and support explicitly. Do not imply unrestricted production permissions.

Strategic Platform Partnership

• Executive briefing -> sovereign/public-sector profile -> legal/procurement review -> strategic program.
• No government approval claim. Jurisdiction-specific legal and data-residency review required. Public-sector claims must be reviewed before publication.

Managed Cloud Pilot Profile

• Vercel application runtime with Supabase Auth/Postgres and Upstash rate limiting.
• Platform license plus protected pilot fee, workflow modules, implementation services, and usage bands after validation.
• Blocked claims: HIPAA certified, SOC 2 certified, production clinical system, autonomous diagnosis

Private Cloud Readiness Profile

• Customer cloud or private-cloud architecture review with SCRIMED runtime components mapped before deployment.
• Annual platform license plus private-cloud implementation, security review, connector scope, and support tier.
• Blocked claims: customer environment approved, private cloud certified, EHR production connected

Hospital-Controlled Runtime Profile

• Hospital-controlled runtime with local policy, identity, audit, and clinical-review ownership.
• Enterprise license plus department workflow modules, integration services, and clinical governance support.
• Blocked claims: clinical decision support authorized, EHR writeback enabled, patient treatment automation

Sovereign Cloud And Public Sector Profile

• Government or sovereign-cloud profile with jurisdiction-specific residency, procurement, and incident ownership.
• Multi-year strategic agreement with jurisdictional customization, regional support, and governance reporting.
• Blocked claims: sovereign compliant, government approved, public health reporting authorized

Edge And On-Prem Evaluation Profile

• Edge or on-prem runtime planning for imaging, device, lab, and facility-signal workflows using synthetic fixtures first.
• Platform module plus device/integration implementation, support, monitoring, and safety review.
• Blocked claims: device control, diagnostic imaging interpretation, medical-device cleared, real-time clinical automation

Healthcare AI Factory Readiness

• Sources: NVIDIA Healthcare and Life Sciences, NVIDIA Technical Blog
• Proof metrics: latency, cost-per-work-order, override rate, escalation rate, evidence completeness
• Blocked claims: production authorized, HIPAA certified, autonomous clinical execution

Patient-Centered Interoperability Layer

• Sources: Epic
• Proof metrics: fixture pass rate, mapping completeness, source attribution coverage, workflow friction reduced
• Blocked claims: EHR-certified integration, live patient sync, clinical decision authorization

Evidence-Backed Agent Workforce

• Sources: OpenAI Developers, NVIDIA Healthcare and Life Sciences, Microsoft Copilot
• Proof metrics: trust score, completion rate, review time, rework rate, citation coverage
• Blocked claims: clinician replacement, autonomous diagnosis, unreviewed treatment plan

Device, Edge, and Facility Integration Pathway

• Sources: AWS Health Care, NVIDIA Healthcare and Life Sciences
• Proof metrics: device fixture coverage, data-quality issues surfaced, mapping accuracy, review escalations
• Blocked claims: medical device control, diagnostic imaging interpretation, facility automation authorized

Outcome Proof and Commercial Channel

• Sources: Epic, NVIDIA Inception, NVIDIA Technical Blog
• Proof metrics: time saved, denial-risk surfaced, revenue leakage identified, conversion stage, sales cycle risk
• Blocked claims: guaranteed savings, guaranteed reimbursement, customer-certified compliance

Executable product proof

Sellable pilot packaging

Protected tenant workspace

Commercial pricing path

Diligence and claims control

No-PHI buyer intake

CarePath Access Operations Demo

• CarePath AI · Scheduling Agent
• 3 linked proof routes

DocuTwin Documentation Review Demo

• DocuTwin · Documentation Agent
• 3 linked proof routes

TrialCore Research Operations Demo

• TrialCore · Trial Matching Agent
• 3 linked proof routes

Atlas Interoperability Readiness Demo

• SCRIMED Atlas · Interoperability Agent
• 3 linked proof routes

AgentOS Governance Evaluation Demo

• SCRIMED AgentOS · Planner, Router, Specialist Agents, and TrustQA
• 3 linked proof routes

PayerIQ Documentation Readiness Demo

• PayerIQ · Documentation-Before-Authorization Agent
• 3 linked proof routes

30-Day Workflow Intelligence Sprint

60-Day Governed Automation Pilot

90-Day Enterprise Atlas Pilot

AI Governance + Interoperability Readiness Pilot

Synthetic Pilot Evaluation

• Product Console, workflow fixtures, result validation, quality gates, and readiness brief.
• Synthetic data only; no live patient routing, diagnosis, order entry, payer submission, or autonomous clinical execution.

Workflow Intelligence Assessment

• Workflow Engine examples, agent registry, integration fixture contracts, and buyer-specific operating map.
• Assessment output is operational intelligence for human leaders; it is not clinical advice or a production automation approval.

AI Readiness + Governance Audit

• Trust and governance controls, runtime safety register, identity register, audit persistence register, and quality gate stack.
• Audit identifies readiness and risk controls; production use requires buyer approval, security review, and implementation validation.

Clinical Operations Automation Blueprint

• Agent registry, deployment stages, service offers, proof stack, and synthetic workflow demonstrations.
• Blueprint remains review-only until approved production controls, live connectors, and human operating procedures are in place.

Prior Authorization Agent

• Human review required
• no autonomous payer submission
• no coverage guarantee

Revenue Cycle Agent

• Human review required
• no final coding decision
• no autonomous claim submission

Scheduling Agent

• Human review required
• no emergency triage replacement
• no autonomous appointment confirmation without configured consent

Trial Matching Agent

• Human review required
• no enrollment recommendation
• no treatment recommendation

Documentation Agent

• Human review required
• draft-only output
• no final clinical note

Compliance Agent

• Human review required
• no silent approval
• exception logging required

Interoperability Agent

• Human review required
• no production data pull
• synthetic-first validation

Clinical Intelligence Agent

• Human review required
• no diagnosis authority
• no treatment order

Research Agent

• Human review required
• no IRB bypass
• no unsupported clinical claim

Governance Agent

• Human review required
• immutable audit trail required
• material change review required

Supply Chain Agent

• Human review required
• no autonomous procurement commitment
• clinical-critical substitution requires human review

Referral intake automation

• No autonomous referral acceptance, clinical triage replacement, or patient-facing action.

Prior authorization support

• No payer submission, coverage guarantee, or clinical necessity determination without human approval.

Patient onboarding triage

• No live patient routing, diagnosis, emergency triage replacement, or autonomous outreach.

Ambient documentation review

• No final note, EHR filing, diagnosis insertion, or record update without licensed clinician review.

RCM denial risk review

• No final coding, billing, appeal, claim submission, or reimbursement claim without qualified review.

Care gap detection

• No diagnosis, treatment recommendation, order entry, or patient instruction without licensed clinician review.

Legal Readiness

Security Readiness

Privacy Readiness

Brand Readiness

AI & Enterprise Governance

Marketing Readiness

Public Relations Readiness

Sales Readiness

Advertising Readiness

SCRIMED Atlas Pilot

CarePath Command

DocuTwin Review

TrialCore Queue

1. Synthetic demo

2. Protected pilot

3. Governed production